Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Garot

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|June 18, 2010
Comparison of zotarolimus-eluting and everolimus-eluting coronary stentsPatrick W Serruys, Sigmund Silber, Scot Garg, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
Circulation. Cardiovascular Interventions|November 18, 2017
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-AnalysisDhaval Kolte, Partha Sardar, Sahil Khera, et al.
Circulation|October 15, 2020
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical TrialCorrado Tamburino, Sabine Bleiziffer, Holger Thiele, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Circulation. Cardiovascular Interventions|February 19, 2026
Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future DirectionsAndrea Ruberti, Eduardo Flores-Umanzor, Laura Sanchis, et al.
Lancet (London, England)|January 11, 2026
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trialAlexandre Abizaid, Roxana Mehran, Angelo Oliva, et al.
JACC. Cardiovascular Interventions|January 22, 2021
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International RegistryGiulio G Stefanini, Enrico Cerrato, Carlo Andrea Pivato, et al.
The American Journal of Cardiology|March 30, 2022
Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39]Imad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 20, 2026
Impact of device implantation depth on blood flow dynamics after left atrial appendage closurePedro Cepas-Guillén, Carlos Albors, Jordi Mill, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|June 18, 2010
Comparison of zotarolimus-eluting and everolimus-eluting coronary stentsPatrick W Serruys, Sigmund Silber, Scot Garg, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER IIIPhilippe Garot, Martin B Leon, Shigeru Saito, et al.
Circulation. Cardiovascular Interventions|November 18, 2017
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-AnalysisDhaval Kolte, Partha Sardar, Sahil Khera, et al.
Circulation|October 15, 2020
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical TrialCorrado Tamburino, Sabine Bleiziffer, Holger Thiele, et al.
The American Journal of Cardiology|May 23, 2016
Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting StentsImad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Circulation. Cardiovascular Interventions|February 19, 2026
Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future DirectionsAndrea Ruberti, Eduardo Flores-Umanzor, Laura Sanchis, et al.
Lancet (London, England)|January 11, 2026
Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trialAlexandre Abizaid, Roxana Mehran, Angelo Oliva, et al.
JACC. Cardiovascular Interventions|January 22, 2021
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International RegistryGiulio G Stefanini, Enrico Cerrato, Carlo Andrea Pivato, et al.
The American Journal of Cardiology|March 30, 2022
Corrigendum to 'Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents'[The American Journal of Cardiology 118 (2016) 32-39]Imad Sheiban, Claudio Moretti, Fabrizio D'Ascenzo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 20, 2026
Impact of device implantation depth on blood flow dynamics after left atrial appendage closurePedro Cepas-Guillén, Carlos Albors, Jordi Mill, et al.
Pageof 26